Hartmut Link

7PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice.

Bastian Wobbe, Viola Andresen, Ralf Baron

|Jan 19, 2024
Anemia diagnosis and therapy in malignant diseases: implementation of guidelines-a representative study.

Hartmut Link, Markus Kerkmann, Laura Holtmann

|Sep 08, 2022
A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany.

Hartmut Link, Stephen F Thompson, Marc Tian

|Mar 08, 2022
Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.

Hartmut Link, Markus Kerkmann, Laura Holtmann

|Sep 18, 2020
Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.

Hartmut Link, G Illerhaus, U M Martens

|Aug 15, 2019
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany.

Hartmut Link, Ingo Diel, Carsten-H Ohlmann

Pageof 2

Frequent Collaborators

1 joint publications

Markus Kerkmann

1 joint publications

Laura Holtmann

1 joint publications

Bastian Wobbe

1 joint publications

Ralf Baron